Drawing for TEEWINOID THERAPIES

USPTO serial 87740723

TEEWINOID THERAPIES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PENDLETON, CAROLYN A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TEEWINOID THERAPIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David D'Zurilla

DAVID D'ZURILLA SCHWEGMAN LUNDBERG & WOESSNER, P.A.P.O. BOX 2938MINNEAPOLIS, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biopharmaceutical drugs for the treatment of pain, inflammation, cancer, seizures, and epilepsyACTIVE—
040Custom manufacture of pharmaceuticals and biopharmaceutical drugs; Custom manufacturing of new biological products for others; Custom manufacture of chemical products for others; Custom manufacture of nutraceuticals for others; Custom manufacture of cosmeceuticals for others; Custom manufacture of medical veterinary products for othersACTIVE—
042Research and development of pharmaceuticals and biopharmaceutical drugs; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering, and organic chemistry; Research and development of new biological products for others; Research and development of new chemical products for others; Nutraceutical research and development for others; Cosmeceutical research and development for others; Veterinary medical research and development for others; Research and development in the field of bioinformatics and proteomicsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 25, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 25, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 24, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2018ALIEASSIGNED TO LIE—
Apr 17, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 17, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 17, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 17, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 11, 2018DOCKASSIGNED TO EXAMINER—
Jan 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 5, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance